RNU6-333P

Across TCGA pan-cancer cohorts, RNU6-333P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-333P data layer.

The strongest signal is observed in thymoma (THYM), where higher RNU6-333P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-333P expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

THYM, READ, and ACC are the cancer types where RNU6-333P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	III,IV	0.103	0.944	<.001	126	view →
READ	OS	Tertile	All	0.166	0.830	<.001	90	view →
ACC	OS	Tertile	All	0.114	0.892	<.001	72	view →
ESCA	OS	Tertile	II,III,IV	0.104	0.926	<.001	36	view →
STAD	OS	Tertile	IV	1.000	0.252	.008	36	view →
HNSC	OS	Tertile	III,IV	0.001	0.675	<.001	36	view →
CESC	DFS	Tertile	II,III,IV	0.173	0.705	.028	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-333P–THYM (OS)

Open the THYM breakdown →